この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2015/4/81 分で読めます
Implantation or Injectable Dosage Form New Animal Drugs; Withdrawal of Approval of New Animal Drug Application; Fomepizole
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is withdrawing approval of a new animal drug application (NADA) for a fomepizole injectable solution used as an antidote for ethylene glycol poisoning in dogs. This action is being taken at the sponsor's request because this product is no longer manufactured or marketed.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →